Eating a high fat diet without getting obese?

Many factors can contribute to obesity, including individual genetics, gut bacteria, and diet. Recently, studies have shown that immune system activity can also have an effect, but the details are still unclear. The team at RIKEN IMS designed an experiment using genetically engineered mice to determine the role of innate lymphoid cells—a type of white blood cell—in diet-related obesity.

The team examined two types of mice, both with missing immune cells. One type lacked acquired immune cells, but did not lack ILCs. The other type lacked all lymphocytes, including ILCs. Along with unmodified mice, they then fed the mice either a normal diet or a high-fat diet for 8 weeks. All mice showed mild weight gain on a normal diet. However, while normal mice and those missing acquired immune cells gained a tremendous amount of weight when given the high-fat diet, mice lacking ILCs did not. In fact, they stayed as lean as those who received the normal diet, even though they ate the same amount of high-fat food as the other two groups of mice.

Photos of the livers from the three mouse groups on high-fat (top row) and normal (bottom row) diets. A normal diet resulted in normal livers. Unmodified mice and mice without any acquired immune cells developed large and fatty livers after eating the high fat diet (top, left and middle). In contrast, the mice without innate immune cells had livers that were just as healthy as those who ate the normal diet (right, compare top and bottom).

Subsequent testing showed that mice lacking ILCs also failed to show other physiological signs of obesity, such as greater amounts of white fat tissue, larger livers, higher blood sugar levels, and impaired insulin resistance. In another experiment, researchers reintroduced ILCs into the ILC-deficient mice through a bone marrow transplant. After 2 months on a high-fat diet, they found that these mice now showed all the symptoms of obesity. With these findings, the team was confident that it was the lack of ILCs that had prevented diet-induced obesity.

There are actually three groups of ILCs, and after testing mice with specific ILC deficits, the team found that those lacking group-2 ILCs were prevented from becoming obese after eating the high-fat diet. “This was surprising,” explains first author Takaharu Sasaki. “In the past, ILC2s from white adipose tissue were shown to help prevent obesity. However, here we found that when they come from the small intestines, they actually promote obesity.”

The researchers confirmed this finding by transferring white fat-ILC2s or small intestine-ILC2s into the mice lacking all ILCs. They found that only the mice who received ILC2s from the small intestine became obese after eating the high-fat diet.

“Now we know that despite a high-fat diet, diet-induced obesity can be prevented by eliminating small intestinal ILC2s,” says Sasaki. “This means that aside from controlling our diets, some function of these cells could be a potential target for obesity treatment. Our next step is therefore to determine how small intestinal ILC2s induce obesity.” ✅

Many factors can contribute to obesity, including individual genetics, gut bacteria, and diet. Recently, studies have shown that immune system activity can also have an effect, but the details are still unclear. The team at RIKEN IMS designed an experiment using genetically engineered mice to determine the role of innate lymphoid cells—a type of white blood cell—in diet-related obesity.

The team examined two types of mice, both with missing immune cells. One type lacked acquired immune cells, but did not lack ILCs. The other type lacked all lymphocytes, including ILCs. Along with unmodified mice, they then fed the mice either a normal diet or a high-fat diet for 8 weeks. All mice showed mild weight gain on a normal diet. However, while normal mice and those missing acquired immune cells gained a tremendous amount of weight when given the high-fat diet, mice lacking ILCs did not. In fact, they stayed as lean as those who received the normal diet, even though they ate the same amount of high-fat food as the other two groups of mice.

Photos of the livers from the three mouse groups on high-fat (top row) and normal (bottom row) diets. A normal diet resulted in normal livers. Unmodified mice and mice without any acquired immune cells developed large and fatty livers after eating the high fat diet (top, left and middle). In contrast, the mice without innate immune cells had livers that were just as healthy as those who ate the normal diet (right, compare top and bottom).

Subsequent testing showed that mice lacking ILCs also failed to show other physiological signs of obesity, such as greater amounts of white fat tissue, larger livers, higher blood sugar levels, and impaired insulin resistance. In another experiment, researchers reintroduced ILCs into the ILC-deficient mice through a bone marrow transplant. After 2 months on a high-fat diet, they found that these mice now showed all the symptoms of obesity. With these findings, the team was confident that it was the lack of ILCs that had prevented diet-induced obesity.

There are actually three groups of ILCs, and after testing mice with specific ILC deficits, the team found that those lacking group-2 ILCs were prevented from becoming obese after eating the high-fat diet. “This was surprising,” explains first author Takaharu Sasaki. “In the past, ILC2s from white adipose tissue were shown to help prevent obesity. However, here we found that when they come from the small intestines, they actually promote obesity.”

The researchers confirmed this finding by transferring white fat-ILC2s or small intestine-ILC2s into the mice lacking all ILCs. They found that only the mice who received ILC2s from the small intestine became obese after eating the high-fat diet.

“Now we know that despite a high-fat diet, diet-induced obesity can be prevented by eliminating small intestinal ILC2s,” says Sasaki. “This means that aside from controlling our diets, some function of these cells could be a potential target for obesity treatment. Our next step is therefore to determine how small intestinal ILC2s induce obesity.” ✅